Research and development as well as technical service capabilities

1 Company Introduction

Business Areas:

Our business covers high difficulty sustained-release and controlled-release preparations, generic drug development based on patent challenges, consistency evaluation of oral and injectable preparations, CMC for innovative drugs/improved new drugs/generic drugs, regulatory filing, and MAH (Marketing Authorization Holder). We have comprehensive, full-lifecycle, process-oriented R&D and technical service capabilities — from early formulation design evaluation and preclinical studies to pilot-scale production, commercial manufacturing, and regulatory submission.

1 Advantageous technical platform

Advantageous Technology Platforms:

· Innovative Drug Technology Platform(synthesis/preparations improvement, innovative drugs)
· Sustained-Release and Controlled-Release Preparations Technology Platform(extended-release, enteric‑coated, osmotic pump)
· Solubility Enhancement Technology Platform for Poorly Soluble Drugs(spray drying, hot melt extrusion)
· Topical Preparations Technology Platform(suppositories, ointments, gels)
· Orally Disintegrating Preparations Technology Platform(orally dissolving films, orally disintegrating tablets)
· Soft Capsule Preparations Technology Platform
· Liquid Preparations Technology Platform(oral solutions, injections (including lyophilized products), eye drops)
Narcotic and Psychotropic Substance R&D Platform

Advantageous Technology Platforms:
Advantageous technical platform
Advantageous Technology Platforms:
Advantageous Technology Platforms:
Advantageous Technology Platforms:
Advantageous Technology Platforms:
Advantageous Technology Platforms:
Advantageous Technology Platforms:

1 R&d and service advantages

R&D and Service Advantages

Expert-level R&D Team

• Technical expert team–Includes an academician in pharmacokinetics, along with professors in preparations and pharmaceutical analysis from China Pharmaceutical University, with over 30 years of experience in tackling innovative R&D challenges.
• Drug review experts are engaged to review and assess technical dossiers, ensuring both technical feasibility and regulatory compliance.

Three Centers Equipped with High-End R&D Instruments

• R&D Center–Approximately 5,700 m², housing the Synthetic Drug Center, Modern Preparations Research Center, Pharmaceutical Analysis Center, and Drug Quality Research Center.
• High-end preparations and analytical instruments – All equipments have passed 3Q qualification.

Robust Quality Management System

• Equipped with networked chromatography data acquisition systems (Shimadzu, Chromeleon, Agilent), supported by a full quality management system that meets "data integrity" requirements.
• Certified under ISO 9001:2015, and has successfully passed nearly 20 regulatory on-site inspections for drug development and for issuance/amendment of MAH license (Type B). 

Service Guarantee

• Project experience– Over 100 projects in R&D and regulatory filing (in China, US, and Europe)
• Approval experience– Over 50 approvals
• Innovative drugs– 6 obtained registration approvals, 5 obtained clinical trial approvals

R&D and Service Advantages